Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs.
about
Nucleolar damage correlates with neurotoxicity induced by different platinum drugsMultidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane VesiclesDifferential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissueLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Membrane transporters as mediators of Cisplatin effects and side effects.Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients.Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradationGyejigachulbu-Tang Relieves Oxaliplatin-Induced Neuropathic Cold and Mechanical Hypersensitivity in Rats via the Suppression of Spinal Glial Activation.Chemotherapy-induced polyneuropathy. Part I. Pathophysiology.Sucralose, a synthetic organochlorine sweetener: overview of biological issuesComparative Pharmacokinetics and Allometric Scaling of Carboplatin in Different Avian SpeciesQuantitative imaging of platinum based on laser ablation-inductively coupled plasma-mass spectrometry to investigate toxic side effects of cisplatin.Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats.Combined Effects of Bee Venom Acupuncture and Morphine on Oxaliplatin-Induced Neuropathic Pain in Mice.Oxaliplatin in the treatment of colorectal cancer.Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2Effect of bee venom acupuncture on oxaliplatin-induced cold allodynia in rats.Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity.Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue.Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats.Uptake carriers and oncology drug safety.Effects of electroacupuncture on oxaliplatin-induced neuropathic cold hypersensitivity in rats.Premature aging-related peripheral neuropathy in a mouse model of progeria.Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy.Exploring the activity of a polyazine bridged Ru(ii)-Pt(ii) supramolecule in F98 rat malignant glioma cells.Highly efficient uptake into cisplatin-resistant cells and the isomerization upon coordinative DNA binding of anticancer tetrazolato-bridged dinuclear platinum(II) complexes.A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).Cellular accumulation, lipophilicity and photocytotoxicity of diazido platinum(IV) anticancer complexes.Platinum compounds for high-resolution in vivo cancer imaging.Gold(I) complexes of water-soluble diphos-type ligands: synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition.Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?Role of platinum DNA damage-induced transcriptional inhibition in chemotherapy-induced neuronal atrophy and peripheral neurotoxicity.Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.Preventive Effects of Bee Venom Derived Phospholipase A₂ on Oxaliplatin-Induced Neuropathic Pain in Mice.Distinct Mechanism of Cysteine Oxidation-Dependent Activation and Cold Sensitization of Human Transient Receptor Potential Ankyrin 1 Channel by High and Low Oxaliplatin.Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what?Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors.Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes.
P2860
Q28364232-83499DE2-0299-425B-A4F8-33404674F7B3Q28546068-14999571-4DDD-475F-9D22-F9A79A7FE580Q28564651-9A321E90-59D6-457E-A3A9-7F95608BD99CQ30366990-F4465750-1964-45E7-88C3-BD31806C6FE7Q30446860-C1DEFC8D-A3E6-477F-A537-6BB96D3215F7Q33669579-75E01450-45CC-4851-9184-A154B63CCEB2Q33770708-857A44AE-0C80-4AC1-8158-5A676A7B9648Q33826355-5FEF4DAA-B45D-44D4-842E-8CA99CBF87C9Q34610876-44397209-EFD2-4BC0-8B0B-0C5061E878BCQ34653461-44E25AEB-DA74-4C8B-9724-B5BA374B6AFEQ34657381-3C36719F-9697-4370-9B7A-33787ECBA015Q35723832-01E0C80D-1BCB-40FE-9D7A-B384EFF169B6Q35811787-D493DA45-3573-4526-B02E-5C7B4638C9DBQ36615327-752F269E-A39F-4F5D-B0CC-F9C528BBD061Q36638304-2568B4D5-9D52-4AB0-911E-8D7AB1618B51Q36788436-C0175B0A-5C6A-4613-AB4E-25BC150EA582Q36991056-000A4128-924A-4AD5-9DA4-331AF5F341F6Q37154821-3B22CF40-931B-4AE9-994E-95E2BF4BD512Q37340539-C4F71E97-0D3A-4A49-900F-5B9E747C6D7AQ37448398-7B298A68-90F7-4239-98A2-1431312ED62CQ37641278-5160ADD5-CDCC-4421-81F1-A5B1353B1F81Q37663396-4A878FFE-736B-4924-A929-F5F983F7C5AEQ38445554-6BAB046A-B694-4474-9978-C42DFD6F6AA2Q38558947-1CE98D9A-DE07-4847-BC4D-E27C785FCF22Q38641139-5F82EAA6-8F22-4680-9EE8-A27E2B983653Q38728302-B667D258-CA1B-4DCD-83F7-2FBBC3D889B2Q38833550-780EC32D-D03E-4929-AC39-D516A8AA85A3Q38878220-A113DD3B-3379-4B50-A536-EDC2085E6DA5Q38993842-3BCD9C6A-9C92-46B7-8906-67DBC765ADB9Q39026285-01BEF418-A13A-45CD-BC13-8A2C34618990Q39493102-0E9EBA09-1000-44F7-826A-6D9FD21A3212Q40071911-D0298FFA-D09B-4215-AAD8-CC5AA2C74583Q42482333-709F5658-37B4-4929-9962-655A8F4BA77EQ42712071-B0A47EBA-B522-441E-96E2-B94CA68D5262Q43066432-D6FDC9C0-F56C-4CC0-9A80-B21457FBA65EQ46256708-3F8C2142-D90F-492F-8C93-C9DE88AE2B17Q48350344-390D1A8F-276B-49CF-BBDC-84DBD7479A41Q50464497-512689FB-4D83-4EA3-9647-9AC5B72F6E71Q53450886-55BFF658-65FE-4A19-B696-6EBB378464B8
P2860
Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Relationships between hydropho ...... of a series of platinum drugs.
@ast
Relationships between hydropho ...... of a series of platinum drugs.
@en
type
label
Relationships between hydropho ...... of a series of platinum drugs.
@ast
Relationships between hydropho ...... of a series of platinum drugs.
@en
prefLabel
Relationships between hydropho ...... of a series of platinum drugs.
@ast
Relationships between hydropho ...... of a series of platinum drugs.
@en
P2093
P2860
P356
P1476
Relationships between hydropho ...... of a series of platinum drugs.
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.1999.1026
P407
P577
2000-02-01T00:00:00Z
P5875
P6179
1042941766